E. Dotan, P. Catalano, L. Lenchik, R. Boutin, X. Yao, J.P. Ohr, K.-H. Lim, N. Vijayvergia, S.R. Chandana, A. Kalyan, R.F. Dunne, D.B. Zhen, D. Li, M.A. Simon, J. Berlin, L.I. Wagner, P.J. O'Dwyer
{"title":"SIOG2024-1-OA-001 对治疗无效的老年转移性胰腺癌患者进行的吉西他滨/Nab-紫杉醇与 5-氟尿嘧啶/亮菌甲素/脂质体伊立替康比较的随机 II 期研究(GIANT EA2186)","authors":"E. Dotan, P. Catalano, L. Lenchik, R. Boutin, X. Yao, J.P. Ohr, K.-H. Lim, N. Vijayvergia, S.R. Chandana, A. Kalyan, R.F. Dunne, D.B. Zhen, D. Li, M.A. Simon, J. Berlin, L.I. Wagner, P.J. O'Dwyer","doi":"10.1016/j.jgo.2024.101845","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"15 7","pages":"Article 101845"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SIOG2024-1-OA-001 Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT EA2186)\",\"authors\":\"E. Dotan, P. Catalano, L. Lenchik, R. Boutin, X. Yao, J.P. Ohr, K.-H. Lim, N. Vijayvergia, S.R. Chandana, A. Kalyan, R.F. Dunne, D.B. Zhen, D. Li, M.A. Simon, J. Berlin, L.I. Wagner, P.J. O'Dwyer\",\"doi\":\"10.1016/j.jgo.2024.101845\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15943,\"journal\":{\"name\":\"Journal of geriatric oncology\",\"volume\":\"15 7\",\"pages\":\"Article 101845\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of geriatric oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1879406824001905\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of geriatric oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1879406824001905","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
SIOG2024-1-OA-001 Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT EA2186)
期刊介绍:
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.
The journal welcomes the submission of manuscripts in the following categories:
• Original research articles
• Review articles
• Clinical trials
• Education and training articles
• Short communications
• Perspectives
• Meeting reports
• Letters to the Editor.